NOTE 4 - CAPITAL STOCK | During the years ended December 31, 2016 and 2015, the Company had no cash subscriptions for shares of its common stock. On November 11, 2015, the Company entered into a one year agreement to obtain assistance in conducting business strategy and communications planning, public financial disclosure reporting, and various matters in connection with directors and other professionals as needed by the Company. In consideration for the services to be provided, the Company granted the consultant 1,469,825 shares of common stock. Those shares were issued on December 11, 2015 and were valued at $29,397, based on market price at the date of the agreement. In addition, the consultant was granted warrants with a five year term, commencing the date of the agreement, to purchase 3,336,060 shares of common stock at a price of $0.02 per share, including a cashless exercise option. The warrants were valued at $66,721 using the Black-Scholes option pricing model with an average risk-free rate of 1.68%, estimated life of 5 years, volatility of 208.7% and dividend yield of 0%. On January 9, 2015, agreements were reached in connection with the loans of $24,696 (CAD $28,650) and $1,767 (CAD $2,050) whereby the loan amounts were to be converted to Company shares at a price of CAD $0.05, to result in the issuance of 573,000 and 41,000 common shares respectively. Those shares were issued on April 6, 2015. On January 9, 2015, an agreement was reached to modify the terms of a loan such that $26,750 of accrued interest together with a premium was to be converted to Company shares at a price of $0.05 per share, to result in the issuance of 535,000 common shares. Those shares were issued on April 6, 2015. Capitalization The authorized capital of the Company is 500,000,000 shares of capital stock, divided into 480,000,000 shares of common stock with a par value of $0.001 per share, and 20,000,000 shares of preferred stock with a par value of $0.001 per share. The Company reserved 10,000,000 shares of common stock for issuance under its new 2016 Omnibus Equity Incentive Plan. No preferred shares have been issued to December 31, 2016 or to the date of issue of these financial statements. To December 31, 2016 and to the date of issue of these financial statements, warrants to purchase 3,336,060 shares of common stock have been issued and none of those warrants have been exercised. At December 31, 2016 the warrants had an intrinsic value of $66,721 based on the exercise price of $0.02 per warrant and a market price of $0.04 per share. No stock options had been issued at December 31, 2016. Warrants Summary of warrant activity and warrants outstanding at December 31, 2016: Number of Warrants Exercise Price Weighted Average Exercise Price Weighted Average Life Remaining (Years) Expiry Date Intrinsic Value Balance December 31, 2014 — — — — — Issued 3,336,060 $ 0.02 $ 0.02 5.00 November 10, 2020 — Expired — — — — — — Exercised — — — — — — Balance December 31, 2015 3,336,060 $ 0.02 $ 0.02 4.86 November 10, 2020 — Issued — — — — — — Expired — — — — — — Exercised — — — — — — Balance December 31, 2016 3,336,060 $ 0.02 $ 0.02 3.86 November 10, 2020 $ 66,721 |